Xiamen, China

Lingyu Cai

This inventor holds 2 USPTO granted patents and 6 published patent applications. Top assignee: Xiamen LP Pharmaceutical Co., Ltd.. Active years: 2022-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lingyu Cai. Retrieved from https://idiyas.com/inventor/lingyu-cai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Lingyu Cai

Introduction

Lingyu Cai is a notable inventor based in Xiamen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral soluble films. His innovative work has led to the filing of two patents, showcasing his expertise and dedication to advancing medical technology.

Latest Patents

Lingyu Cai's latest patents focus on the preparation of aripiprazole oral soluble films. The first patent describes a method for creating an aripiprazole oral soluble film that contains 10-60% w/w of aripiprazole in a crystalline state and 30-95% w/w of one or more film-forming materials. The film is designed to ensure that 90% of the aripiprazole particles are sized at or below 14.3 micrometers, allowing for a uniform blend without visible undispersed particles. This formulation is noted for its excellent bioavailability, uniformity, stability, and palatability. The preparation process involves grinding aripiprazole particles to achieve the desired size, blending them with film-forming materials in an aqueous solution, defoaming the mixture, and then coating and drying it to form the final film.

Career Highlights

Lingyu Cai is currently associated with Xiamen LP Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has not only contributed to the company's portfolio but has also advanced the field of drug delivery systems.

Collaborations

Lingyu Cai collaborates with talented individuals such as Rongbin Ling and Fuxiang Lin, who contribute to his research and development efforts. Their teamwork enhances the innovative processes within their projects.

Conclusion

Lingyu Cai's contributions to the development of aripiprazole oral soluble films exemplify his commitment to innovation in pharmaceuticals. His patents reflect a significant advancement in drug formulation technology, which can greatly benefit patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…